SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor Meeting22-11-2021
22-11-2021
Sun Pharma recalls products in US market
The US arm of the domestic pharma major is recalling Tadalafil tablets in the American market, according to the latest enforcement report of the US Food and Drug Administration (USFDA).21-11-2021
Without innovation Indian pharma cannot touch $130 bn by 2030: Industry
Sun Pharma says it eyes $1.5 bn from innovative products in 3-4 years19-11-2021
Sun Pharmaceutical Industries Ltd - 524715 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201517-11-2021
Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor Meeting12-11-2021
Anti-COVID-19 pill: Sun Pharma plans India launch, waits for DCGI approval
In a statement, Sun Pharmaceutical Industries has said that it is gearing up to introduce Merck Sharp Dohme (MSD) and Ridgeback's molnupiravir under the brand name Molxvir in India.12-11-2021
Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release relating to Sun Pharma gearing up to introduce Merck Sharpe Dohme (MSD) and Ridgeback's molnupiravir under the brand name Molxvir(r) in India.11-11-2021
Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of the Company''s Q2FY22 earnings conference call.11-11-2021
Sun Pharmaceutical Industries Ltd - 524715 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 10, 2021 for Sudhir Vrundavandas Valia10-11-2021
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 09, 2021 for Shanghvi Finance Pvt Ltd09-11-2021